Kristin K H Neuman

Title: Kristin K H Neuman: Innovator in Oligonucleotide Technology

Introduction

Kristin K H Neuman is a prominent inventor based in Larchmont, NY (US), known for her significant contributions to the field of oligonucleotide technology. With a total of four patents to her name, she has made remarkable advancements that have the potential to impact medical research and treatment.

Latest Patents

One of her latest patents is focused on multimeric oligonucleotides having decreased kidney clearance. This invention relates to methods of administering multimeric oligonucleotides with monomeric subunits joined by linkers. These oligonucleotides possess a molecular weight of at least about 45 kD, which reduces their clearance due to glomerular filtration. Additionally, she has developed defined multi-conjugate oligonucleotides that can have predetermined sizes and compositions. These oligonucleotides can enhance intracellular delivery and multi-gene silencing effects, making them valuable for reducing gene expression and treating medical conditions.

Career Highlights

Kristin is currently associated with Mpeg La, L.L.C., where she continues to innovate and develop new technologies. Her work has positioned her as a key figure in the field of oligonucleotide research.

Collaborations

Throughout her career, Kristin has collaborated with notable professionals, including Jonathan Miles Brown and Hans-Peter Vornlocher. These collaborations have further enriched her research and development efforts.

Conclusion

Kristin K H Neuman's contributions to oligonucleotide technology demonstrate her innovative spirit and commitment to advancing medical research. Her patents reflect her expertise and the potential for significant advancements in the field.